Chief, Metabolic Bone Disorders Unit, National Institutes of Health
Alison Boyce, MD is a pediatric endocrinologist and Chief of the Metabolic Bone Disorders Unit in the National Institute of Dental and Craniofacial Research, National Institutes of Health. The goal of her work is to enhance health and well-being for children with skeletal disorders by developing novel tools and treatments informed by pathophysiologic studies. She leads investigations in fibrous dysplasia/McCune-Albright syndrome, a rare disease affecting the bone and endocrine systems, and has characterized many aspects of this disorder and its treatment. Dr Boyce is a faculty member in the NIH Endocrinology fellowship training program. She is a member of the Fibrous Dysplasia/McCune-Albright Syndrome International Consortium and serves as Chair of the Medical Advisory Committee to the FD/MAS Alliance.